Tesamorelin is a stabilised synthetic analogue of endogenous GHRH, FDA-approved for HIV-associated lipodystrophy and widely studied as an RUO compound in metabolic research. Applications include GH secretion studies, visceral adiposity models, and GH/IGF-1 axis characterisation. Supplied as acetate salt, lyophilised, purity ≥98%. For research use only.

Why customers choose us — benefits and guarantees.

Delivery times, returns policy and related info.